Biggest Drug Maker
- All
- News
-
India Ready To Export Fever Drugs To China Amid Covid Outbreak: Report
India, one of the world's biggest drug makers, is ready to step up exports of fever medicines to China as it reels from a spike in COVID-19 cases, the chairperson of India'sdrug export body said on Thursday.
-
Serum Institute Seeks India Trial Of A Second Covid Vaccine
The Serum Institute of India, the world's biggest vaccine makers, has sought the drug regulator's permission to conduct a small domestic trial of the Novavax Inc COVID-19 vaccine that was found to be 89.3% effective in a UK trial, its CEO told Reuters on Friday.
-
COVID-19: Vaccine Makers Face Biggest Medical Manufacturing Feat In History
The supply chain of a potential vaccine stretches from Pune in India to England's Oxford and Baltimore in the United States
-
Sun Pharma Enters Dermatology Segment To Expand Retail Offering
The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product.
-
How to Spend $5 Trillion: a Record-Breaking Year in Deals
Companies around the world spent a record $5.04 trillion on acquisitions in 2015, according to Dealogic, as slow worldwide economic growth and low interest rates pushed companies to combine forces.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Set to Buy Allergan in Largest Deal Ever in Healthcare Sector: Report
Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, creating the world's biggest drug maker, according to people familiar with the matter.
-
Asia's Biggest Vaccine Maker to Seek Fast-Track Nod for Dengue Drug in India
Serum Institute of India, Asia's largest vaccine maker, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.
-
Indian Drug Makers to Pay Higher Facility Fees on US Hike
Drug makers from India, the biggest source of medicines to the US, may soon have to cough up 12-15 per cent more in annual facility fees as the Food and Drug Administration (FDA) has announced new rates.
-
GSK sells thrombosis drug brand to Aspen For $1 billion
Britain's biggest drug maker, GlaxoSmithKline, on Monday gave nod to the sale of its thrombosis drug brands and a related factory to Aspen Pharmacare as part of its strategy to focus on growth products.
-
Lupin shares down after court rules in favour of J&J
Shares in Lupin, India's third biggest drug maker by market capitalization, traded with deep cuts Thursday after it lost a litigation against global pharma major Johnson & Johnson.
-
India Ready To Export Fever Drugs To China Amid Covid Outbreak: Report
India, one of the world's biggest drug makers, is ready to step up exports of fever medicines to China as it reels from a spike in COVID-19 cases, the chairperson of India'sdrug export body said on Thursday.
-
Serum Institute Seeks India Trial Of A Second Covid Vaccine
The Serum Institute of India, the world's biggest vaccine makers, has sought the drug regulator's permission to conduct a small domestic trial of the Novavax Inc COVID-19 vaccine that was found to be 89.3% effective in a UK trial, its CEO told Reuters on Friday.
-
COVID-19: Vaccine Makers Face Biggest Medical Manufacturing Feat In History
The supply chain of a potential vaccine stretches from Pune in India to England's Oxford and Baltimore in the United States
-
Sun Pharma Enters Dermatology Segment To Expand Retail Offering
The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product.
-
How to Spend $5 Trillion: a Record-Breaking Year in Deals
Companies around the world spent a record $5.04 trillion on acquisitions in 2015, according to Dealogic, as slow worldwide economic growth and low interest rates pushed companies to combine forces.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Set to Buy Allergan in Largest Deal Ever in Healthcare Sector: Report
Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, creating the world's biggest drug maker, according to people familiar with the matter.
-
Asia's Biggest Vaccine Maker to Seek Fast-Track Nod for Dengue Drug in India
Serum Institute of India, Asia's largest vaccine maker, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.
-
Indian Drug Makers to Pay Higher Facility Fees on US Hike
Drug makers from India, the biggest source of medicines to the US, may soon have to cough up 12-15 per cent more in annual facility fees as the Food and Drug Administration (FDA) has announced new rates.
-
GSK sells thrombosis drug brand to Aspen For $1 billion
Britain's biggest drug maker, GlaxoSmithKline, on Monday gave nod to the sale of its thrombosis drug brands and a related factory to Aspen Pharmacare as part of its strategy to focus on growth products.
-
Lupin shares down after court rules in favour of J&J
Shares in Lupin, India's third biggest drug maker by market capitalization, traded with deep cuts Thursday after it lost a litigation against global pharma major Johnson & Johnson.
